Certolizumab Pegol Effectiveness and Retention Rate in Psoriatic Arthritis. Real Life Data

被引：0

作者：

Conesa, Arantxa ^{[1
]}

Fernandez, Manuel ^{[2
]}

Exposito, Rosa ^{[3
]}

Campos, Jose ^{[4
]}

Ramon Lamua, Jose ^{[5
]}

del Pilar Navarro, Maria ^{[6
]}

Rubio-Munoz, Paula ^{[7
]}

Ahijado-Guzman, Pilar ^{[8
]}

Gonzalez, Carlos M. ^{[9
]}

机构：

[1] Hosp Clin Univ Valencia, Valencia, Spain

[2] Hosp Univ Guadalajara, Guadalajara, Spain

[3] Hosp Comarcal Laredo, Rheumatol, Laredo, Spain

[4] Hosp Univ Puerta de Hierro Majadahonda, Rheumatol, Madrid, Spain

[5] Hosp Henares, Madrid, Spain

[6] Hosp Fuenlabrada, Fuenlabrada, Spain

[7] Hosp Univ Germans & Trias Pujol, Rheumatol, Badalona, Spain

[8] Fuenlabradas Hosp, Rheumatol Unit, Madrid, Madrid, Spain

[9] Hosp Gen Univ Gregorio Maranon, Rheumatol, Madrid, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1518

引用

页数：3

共 50 条

[41] The Effect of Certolizumab Pegol on Skin Manifestations of Psoriatic Arthritis over 4 Years of Treatment
Khraishi, Majed
Gottlieb, Alice B.
Hoepken, Bengt
Peterson, Luke
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[42] COST-UTILITY ANALYSIS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS IN GREECE
Tzanetakos, C.
Vassilopoulos, D.
Kourlaba, G.
Christou, P.
Maniadakis, N.
VALUE IN HEALTH, 2015, 18 (07) : A646 - A647
[43] Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Roberta Ramonda
Mariagrazia Lorenzin
Maria Sole Chimenti
Fabiola Atzeni
Angelo Semeraro
Salvatore D’Angelo
Carlo Selmi
Augusta Ortolan
Antonio Marchesoni
Maria Manara
Michele Maria Luchetti Gentiloni
Leonardo Santo
Carlo Salvarani
Alberto Cauli
Maurizio Rossini
Giorgio Amato
Giacomo Cozzi
Laura Scagnellato
Mario Ferraioli
Antonio Carriero
Elena Fracassi
Francesco Giorgio
Andrea Doria
Rosario Foti
Antonio Carletto
Arthritis Research & Therapy, 26 (1)
[44] ONE-YEAR EFFECTIVENESS, RETENTION RATE AND SAFETY OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A REAL-LIFE MULTICENTRE STUDY
Chimenti, M. S.
Fonti, G. L.
Conigliaro, P.
Sunzini, F.
Scrivo, R.
Navarini, L.
Triggianese, P.
Peluso, G.
Scolieri, P.
Caccavale, R.
Picchianti-Diamanti, A.
De Martino, E.
Salemi, S.
Birra, D.
Altobelli, A.
Paroli, M.
Bruzzese, V.
Lagana, B.
Gremese, E.
Conti, F.
Afeltra, A.
Perricone, R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 716 - 716
[45] One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study
Chimenti, Maria Sole
Fonti, Giulia Lavinia
Conigliaro, Paola
Sunzini, Flavia
Scrivo, Rossana
Navarini, Luca
Triggianese, Paola
Peluso, Giusy
Scolieri, Palma
Caccavale, Rosalba
Diamanti, Andrea Picchianti
De Martino, Erica
Salemi, Simonetta
Birra, Domenico
Altobelli, Alessio
Paroli, Marino
Bruzzese, Vincenzo
Lagana, Bruno
Gremese, Elisa
Conti, Fabrizio
Afeltra, Antonella
Perricone, Roberto
EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (07) : 813 - 821
[46] Certolizumab-pegol/leflunomide/tocilizumabAllergy and paradoxical psoriasis and psoriatic arthritis: case report
Reactions Weekly, 2023, 1974 (1) : 103 - 103
[47] New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol
Cauli, Alberto
Piga, Matteo
Lubrano, Ennio
Marchesoni, Antonio
Floris, Alberto
Mathieu, Alessandro
JOURNAL OF RHEUMATOLOGY, 2015, 42 : 70 - 72
[48] CERTOLIZUMAB PEGOL PERSISTENCE AND ADHERENCE BY DRUG FORMULATION, IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, OR RHEUMATOID ARTHRITIS
Beaty, S.
Zichlin, M. L.
Hopson, S.
Devine, F.
Pi, S.
Moore, J.
Swallow, E.
VALUE IN HEALTH, 2022, 25 (07) : S561 - S561
[49] ARE THERE ANY DIFFERENCES IN THE EFFECTIVITY AND SAFETY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS ACCORDING THEIR GENDER?
Garcia, Rosa
Fernandez-Prada, Manuel
Conesa, Arantxa
Campos Esteban, Jose
Urruticoechea-Arana, Ana
Olive, Alejandro
Paredes, Silvia
Taverner, Delia
Gonzalez, Carlos
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1840 - 1840
[50] Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Florenzo Iannone
Angelo Semeraro
Giorgio Carlino
Leonardo Santo
Romano Bucci
Laura Quarta
Nicola Maruotti
Carmelo Zuccaro
Antonio Marsico
Paola Chiara Francesca Falappone
Daniela Mazzotta
Francesco Paolo Cantatore
Maurizio Muratore
Giovanni Lapadula
Clinical Drug Investigation, 2019, 39 : 565 - 575

← 1 2 3 4 5 →